FIDAS-3

SKU: orb1309673

Description

FIDAS-3 is a stilbene-based small molecule that potently inhibits MAT2A (IC50 = 4.9 µM) by competing with its cofactor SAM. This Wnt pathway inhibitor demonstrates anticancer activity and is a useful chemical probe for studying methionine metabolism and epigenetics in cancer cell lines and in vivo models.

Research Area

Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology

Key Properties

• CAS Number: 1266684-01-8
• MW: 259.29
• Purity: 98.59% (May vary between batches)
• Formula: C₁₆H₁₅F₂N
• SMILES: CN(C)c1ccc(\C=C\c2c(F)cccc2F)cc1
• Target: Wnt/beta-catenin,Methionine Adenosyltransferase (MAT)
• Solubility: DMSO:90 mg/mL (347.1 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (12.73 mM)

Bioactivity

• Target IC50:
  Mat2A:4.9 μM
• In Vivo:
  FIDAS-3 (20 mg/kg;intraperitoneal injection;daily;for one months;C57BL/6J athymic nude mice) treatment significantly inhibits the growth of xenograft tumors.
  Read more...
• In Vitro:
  FIDAS-3 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-3 (10 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-3 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells. FIDAS-3 (3-10 μM) treatment inhibits the expression of c-Myc and cyclinD1 in LS174T CRC cells.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Wnt, Wnt/b-catenin, Wnt/betacatenin, Wnt/β-catenin, SAH, S-adenosylmethionine, SAM, βcatenin, β-catenin, CyclinD1, c-Myc, beta-catenin, betacatenin, bcatenin, anti-cancer, anti-proliferation, Methionine Adenosyltransferase, Methionine Adenosyltransferase (MAT), Methionine S-adenosyltransferase 2A(MAT2A), MethionineAdenosyltransferase(MAT), MethionineAdenosyltransferase, inhibit, Inhibitor, FIDAS 3, FIDAS3, FIDAS-3, MAT, MAT2A, MATA2

Compound Identifiers

PubChem CID

51039205